Literature DB >> 786520

Heterogeneity of stem cells in severe combined immunodeficiency.

G S Incefy, E Grimes, W A Kagan, G Goldstein, E Smithwick, R O'Reilly, R A Good.   

Abstract

Two patients with severe combined immunodeficiency disease (SCID) having variable B-cell development have been shown to have marrow precursors of lymphoid cells which can be induced in vitro by thymic factors to express certain T-cell surface characteristics (HTLA+ phenotypes). Their marrow cells could not, however, be induced by these same factors to develop the E-rosette marker or functional activities of T lymphocytes. The marrow of these children also showed, when compared to that of normal adults, a different distribution of cellular elements on density gradient fractionation. The findings support the view that the disorder under study has a different pathogenesis from other forms of SCID previously analysed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 786520      PMCID: PMC1541399     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells.

Authors:  G Goldstein; M Scheid; U Hammerling; D H Schlesinger; H D Niall; E A Boyse
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

2.  Immunologic reconstitution in the DiGeorge syndrome by fetal thymic transplant.

Authors:  W W Cleveland
Journal:  Birth Defects Orig Artic Ser       Date:  1975

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Isolation of bovine thymin: a polypeptide hormone of the thymus.

Authors:  G Goldstein
Journal:  Nature       Date:  1974-01-04       Impact factor: 49.962

5.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

Review 6.  Primary immunodeficiencies. Report of a World Health Organization Committee.

Authors:  H Fudenberg; R A Good; H C Goodman; W Hitzig; H G Kunkel; I M Roitt; F S Rosen; D S Rowe; M Seligmann; J R Soothill
Journal:  Pediatrics       Date:  1971-05       Impact factor: 7.124

7.  T-lymphocyte differentiation in vitro in primary immunodeficiency diseases.

Authors:  J L Touraine; G S Incefy; F Touraine; P L'Esperance; F P Siegal; R A Good
Journal:  Clin Immunol Immunopathol       Date:  1974-11

8.  Presence of plasma cells and gamma-1-M-globulin synthesis in a patient with thymic alymphoplasia.

Authors:  P Fireman; H A Johnson; D Gitlin
Journal:  Pediatrics       Date:  1966-03       Impact factor: 7.124

9.  Severe combined immunodeficiency with B lymphocytes and with normal MLC response.

Authors:  M Seligmann; C Griscelli; J L Preud'homme; M Sasportes; C Herzog; J C Brouet
Journal:  Birth Defects Orig Artic Ser       Date:  1975

10.  Fetal thymus transplantation: experimental and clinical observations.

Authors:  W D Biggar; B Y Park; O Stutman; K Gajl-Peczalska; R A Good
Journal:  Birth Defects Orig Artic Ser       Date:  1975
View more
  7 in total

Review 1.  Combined immunodeficiency and thymic abnormalities.

Authors:  A D Webster
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

2.  T-lymphocyte differentiation in vitro in severe combined immunodeficiency. Defects of stem cells.

Authors:  R N Pahwa; S G Pahwa; R A Good
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

3.  Thymic activity in severe combined immunodeficiency diseases.

Authors:  G S Incefy; M Dardenne; S Pahwa; E Grimes; R N Pahwa; E Smithwick; R O'Reilly; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

4.  Rationale for combined use of fetal liver and thymus for immunological reconstitution in patients with variants of severe combined immunodeficiency.

Authors:  R Pahwa; S Pahwa; R A Good; G S Incefy; R J O'Reilly
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

5.  Heterogeneity of b lymphocyte differentiation in severe combined immunodeficiency disease.

Authors:  S G Pahwa; R N Pahwa; R A Good
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

6.  Induction of differentiation in human marrow T cell precursors by the synthetic serum thymic factor, FTS.

Authors:  G S Incefy; R Mertelsmann; K Yata; M Dardenne; J F Bach; R A Good
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

7.  Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.

Authors:  M Fiorilli; M C Sirianni; F Pandolfi; I Quinti; U Tosti; F Aiuti; G Goldstein
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.